arrow
T

Tina Bhutani

University of California, San Francisco
H指数:37
被引数:7,337

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial

zasocitinib(TAK-279),一种高选择性口服TYK2抑制剂,在患有中重度斑块状银屑病患者的皮肤清除中表现出效:一项随机IIb期试验的事后分析

2026-05-160
OA
Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium

不同年龄段外阴银屑病护理的考量:外阴银屑病健康联盟发起的一项改良德尔菲共识倡议

2026-05-130
OAAI
Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative

复杂难治型银屑病关节炎和治疗抵抗型银屑病关节炎的共识定义:GRAPPA倡议

2025-11-270
PRE
Tapinarof Cream for Adults and Children with Atopic Dermatitis—Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials

他皮纳洛芬乳膏用于成人及儿童特应性皮炎的治疗——基于种族和菲茨帕特里克皮肤分型的疗效分析:两项III期随机临床试验

2025-07-220
OAAI
Improving Diversity in a Novel Psoriasis Study VISIBLE as a Framework for Clinical Trial Quality Improvement

提高多样性在新型银屑病研究VISIBLE中,作为一种临床试验质量改进的框架

2024-12-113
PRE
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis
2024-12-011
PRE
Tapinarof cream 1% once daily is efficacious for the treatment of atopic dermatitis in patients with skin of color down to 2 years of age in two pivotal phase 3 trials

在两项关键的3期试验中,每天一次1% 的Tapinarof乳膏可有效治疗2岁以下皮肤颜色的特应性皮炎

2024-08-080
PRE